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Abstract
Conventional CT, MR, and digital subtraction angiography rely on the presence of luminal narrowing for the
identification of vascular pathology offering limited insight into the offending pathophysiologic mechanism
affecting the vessel. High-resolution MRI vessel wall imaging (VWI) has the potential to directly depict and
characterize vessel wall pathology affecting the intracranial circulation increasing diagnostic accuracy for
vasculopathies with similar angiographic findings.
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Background
Blood flow and CSF suppression are essential for optimal
vessel wall visualization in the intracranial circulation
[1]. Intracranial VWI is especially challenging due to the
small caliber and tortuosity of the intracranial vessels
necessitating submilimeter spatial resolution and high
field strength magnets [1–3]. Black blood MRI (BBMRI)
sequences are designed to achieve blood flow suppres-
sion and have historically utilized 2-dimensional (2D)
pre- and postcontrast T1- or proton-weighted sequences
to characterize the vessel wall [1, 3]. The 2D sequences
are prone to partial volume artifacts, which are accentu-
ated by the tortuosity and small size of intracranial
vessels [2]. Three-dimensional (3D) sequences have
more recently become achievable and have the advan-
tage of a large field of view, which allows substantial
coverage in a single acquisition in a clinically acceptable
scan time obviating the need for prospective slice place-
ment, and isotropic resolution, which allows post hoc re-
construction along the short and long axis of vessels
minimizing overestimation of wall thickness (Fig. 1) [2].
Specific vessel wall characteristics that are sought on
VWI include vessel wall thickening (smooth, irregular,
circumferential, concentric, eccentric), signal, and en-
hancement [4]. A short axis view perpendicular to an
intracranial vessel is best for evaluation of vessel wall
thickening and pattern of enhancement (Fig. 1b). In this
text we review the major current applications of BBMRI
in the intracranial circulation.
Atherosclerosis
The hallmark of atherosclerosis on BBMRI is the hetero-
geneity of the thickened vessel wall due to various plaque
components, which may include lipid core, fibrous cap,
intraplaque hemorrhage [5], calcifications, and enhance-
ment (Figs. 1, 2, 3 and 4) [1, 6]. These components are
better demonstrated in the extracranial circulation due to
the larger vessel size, and current MRI techniques cannot
characterize consistently individual intracranial athero-
sclerotic disease (ICAD) components [3, 6]. Nevertheless,
plaque features detected by BBMRI, such as enhancement
and hemorrhage, have been shown to relate to down-
stream strokes (Figs. 1, 2, 3 and 4) [5–7]. Furthermore,
BBMRI can detect small atherosclerotic plaques in vessels
that are not yet stenosed even in advanced atherosclerosis
due to remodeling [1, 8]. Subtle atherosclerotic changes,
including wall thickening and positive remodeling, have
been observed in non-stenotic arteries in stroke patients
when compared with controls [9, 10]. Atherosclerotic
changes identified on BBMRI in non-stenotic intracranial
arteries appear to be the most significant risk factor for
white matter hyperintensities [11].
Atherosclerotic plaques in the intracranial circulation
tend to present as eccentric and usually irregular wall
thickening with or without luminal stenosis and variable
enhancement (Figs. 1, 2, 3 and 4) [3, 6, 7, 12]. When
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compared with reversible cerebral vasoconstriction syn-
drome (RCVS) and vasculitic lesions, ICAD lesions are
significantly more likely to have eccentric wall involve-
ment [3], and can demonstrate lesional T2 hyperintensity
presumably corresponding to the fibrous cap (80 % sensi-
tivity), which presents as a T2 juxtaluminal hyperintense
band occasionally overlying a T2 hypointense component,
the lipid core [12]. T2 hyperintensities and heterogeneous
signal are reportedly absent in vasculitis and RCVS [12].
Luminal narrowing can be identified with conventional
angiographic studies, and the goal of VWI is the definite
characterization of a focal stenotic lesion as athrosclerosis,
Fig. 1 Utility of 3D BBMRI. Postcontrast 3D BBMRI images (acquired resolution, 0.52 mm isotropic) of the left middle cerebral artery (MCA) M1
segment in a 48 year old man with hypertension, diabetes, and coronary artery disease who presented with acute on subacute left MCA territory
infarctions. Long axis (a) and short axis (b) reconstructions demonstrate eccentric thickening and intense enhancement of the M1 segment vessel
wall (arrows)
Fig. 2 Maximum intensity reconstruction (MIP) from a contrast-enhanced MRA (a) and postcontrast 2D BBMRI (b) images through a right vertebral
artery plaque in a 49 year old woman with multifocal intracranial arterial narrowing presenting with an acute distal anterior cerebral artery infarction.,
The 2D BBMRI slice (b), positioned through focal narrowing of the proximal V4 segment of the right vertebral artery (a, line), demonstrates eccentric
wall thickening and enhancement (arrowhead) with central hypointesity (arrow) representing a partially calcified core. BBMRI was achieved using
double inversion recovery with the inversion time set to the null point of blood
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the discrimination of active and stable plaques, and the
demonstration of nonstenotic atherosclerotic burden. In a
recent study, atherosclerotic plaques involving the basilar
artery were more frequently identified on BBMRI than on
time-of-flight MRA [13].
Plaque enhancement can be used to identify lesions re-
sponsible for cerebrovascular ischemic events (Fig. 1).
Plaque enhancement could represent inflammation and/
or neovascularization and a more strongly enhancing
intracranial plaque more likely represents the culprit
lesion for an ischemic event [6, 7, 14]. Enhancement in
an ICAD lesion that causes more than 50 % stenosis has
been shown to be associated with its likelihood to have
caused a recent ischemic event, and this is independent
of plaque thickness [6]. Strong plaque enhancement has
been observed in the vessel supplying the stroke
Fig. 3 Imaging through the cavernous carotid arteries of a 56 year old HIV positive man with type 1 diabetes who presented with acute left MCA
territory infarcts. Postcontrast 3D BBMRI through the short axes of the juxtasellar cavernous ICA segments demonstrates eccentric wall enhancement
and thickening on the left compatible with atherosclerotic plaque with a hypointense rim (arrowhead) that is highlighted by surrounding venous
enhancement and compatible with calcifcation. A hypoenhancing focus (white arrow) within the enhancing, thickened wall suggests a lipid core. A
small atherosclerotic plaque with minimal enhancement is seen on the right (black arrow)
Fig. 4 Imaging of the basilar artery terminal branches in a 55 year old man with acute medial bithalamic infarctions. 3D time-of-flight
MRA MIP image through the distal basilar artery shows a focal high grade stenosis of the left posterior cerebral artery (PCA) P1 segment.
2D postcontrast BBMRI image (b) oriented through the short axis of the stenosed vessel (a, line) demonstrates circumferential eccentric
wall thickening and enhancement (arrow) compatible with an atherosclerotic plaque
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territory within 4 weeks of the ischemic insult, and the
enhancement decreased following the ictus [6, 15].
Plaque enhancement might serve as a more precise
marker of stroke risk than luminal stenosis, enabling risk
stratification in low-grade or even angiographically oc-
cult lesions [6]. Qiao et al. observed a lack of contrast
enhancement only in nonculprit plaques [6]. This sug-
gests that BBMRI can identify stable plaques with lack of
enhancement, which might not need aggressive treat-
ment [6], though a prospective study is needed to valid-
ate plaque enhancement as a predictor of future events.
The effects of intracranial thromboembolism and re-
canalization have been described in a small number of
patients, and include smooth concentric wall thickening
and enhancement at the site of recent arterial occlusion,
which is more common in patients who received mech-
anical thrombectomy than in patients treated with med-
ical therapy alone [16]. This pattern of enhancement
following thrombectomy is reminiscent of and could be
potentially confused with central nervous system (CNS)
vasculitis if the patient’s history is unknown. BBMRI also
has been used for the identification of eccentric
atherosclerotic plaques in the basilar artery and their re-
lationship to the ostia of the major side branches before
basilar artery stenting to minimize procedural complica-
tions [17].
Vasculitis
CNS vasculitis represents inflammation of intracranial
blood vessels [18]. CNS vasculitis is rare and represents
a group of diseases with various underlying mechanisms
that affect vessels of different sizes and are characterized
by non-atheromatous inflammation and necrosis of the
arterial wall [14]. Conventional angiographic findings of
vasculitis when present include multifocal luminal ir-
regularities and stenosis, which are nonspecific and can-
not reliably differentiate vasculitis from atherosclerosis
and RCVS. In contrast to intracranial atherosclerosis,
wall thickening and enhancement in vasculitis tends to
be homogeneous, circumferential and concentric. How-
ever, there is overlap with ICAD, and ICAD lesions can
present with circumferential vessel wall involvement,
and vasculitic lesions can demonstrate eccentric en-
hancement [3, 7, 12, 14, 19]. Hyperintense T2 signal has
been shown to be absent in vasculitic lesions, and a con-
centric enhancing lesion with hyperintense or heteroge-
neous T2 signal is more likely ICAD [12]. In our clinical
experience, vasculitic enhancement and inflammation
can occasionally extend beyond the vessel wall to involve
the adjacent perivascular space and/or brain parenchyma
(Fig. 5). We hypothesize that this periadventitial en-
hancement might represent a specific pattern of involve-
ment in vasculitis. Finally, 3D black blood sequences can
be used for intraoperative navigation to target individual
vascular branches to increase diagnostic yield when bi-
opsy is contemplated in suspected cases of vasculitis.
Reversible cerebral vasoconstriction syndrome
RCVS is a noninflammatory disorder of arterial tone
regulation, which results in multifocal segmental nar-
rowing of cerebral arteries that resolves spontaneously
within 3 months [14, 20]. The main differential consider-
ation is vasculitis especially when there are overlapping
clinical features; and discrimination between the two
Fig. 5 Brain imaging in a 79 year old man with biopsy confirmed amyloid-β-related angiitis. Extensive confluent T2 FLAIR hyperintense
vasogenic edema (a) and multiple punctate cortical foci of susceptibility (b) are seen in the right frontal and parietal lobes. Axial postcontrast 3D BBMRI
(c) demonstrates 3 small cortical arteries with patent central hypointense lumen (arrows), and extensive circumferential wall enhancement, which
appears to extend into the adjacent perivascular brain parenchyma compatible with vasculitis
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conditions is important because vasculitis is treated with
steroids, which can be harmful in RCVS [4, 20, 21].
Angiographic imaging fails to distinguish the two condi-
tions due to nonspecific luminal narrowing in both [19].
A pilot VWI study that assessed consecutive cases with
multifocal segmental narrowing on angiographic imaging
demonstrated vessel wall thickening and enhancement
in CNS vasculitis and cocaine vasculopathy, and minimal
to no enhancement in RCVS [20]. Cocaine vasculopathy
creates vasospasm, but unlike RCVS it results in arterial
wall inflammation on histopathologic evaluation [22]. A
larger study recruited 13 vasculitis and 13 RCVS patients
[19]. Twelve out of 13 vasculitis patients had wall thick-
ening and enhancement. The enhancement involved a
short segment and was concentric in 9 patients and ec-
centric in 3 [19]. In RCVS, 10 patients had diffuse uni-
form wall thickening continuous throughout the entire
wall of the diseased vessel likely due to smooth muscle
contraction [20], and only 4 patients had mild vessel wall
enhancement [19]. Wall enhancement in RCVS was less
intense compared to CNS vascultis with early resolution
within 3 months when present [19]. These results sug-
gest that BBMRI is helpful in the differentiation of RCVS
from CNS vasculitis.
Aneurysm
A pilot study in 5 patients with aneurysmal subarach-
noid hemorrhage demonstrated thick vessel wall en-
hancement in all ruptured aneurysms, and absent
enhancement in the unruptured aneurysms [23]. In a
larger study that included 117 patients, there was strong
aneurysmal wall enhancement in 73.8 % of ruptured ver-
sus 4.8 % of unruptured aneurysms [24]. The authors
concluded that in patients with multiple aneurysms and
subarachnoid hemorrhage the presence of aneurysmal
wall enhancement will likely identify the ruptured lesion
[23, 24]. However, it is important to note that these are
retrospective investigations and the enhancement could
be a consequence of the rupture. In surgically treated
aneurysms with partial wall enhancement, the enhance-
ment corresponded to the point of rupture during sur-
gery, which might be helpful in treatment planning [24].
In another study that included 87 patients with 108
aneurysms, circumferential aneurysmal wall enhance-
ment was more frequently seen in unstable than in
stable aneurysms (87 % versus 28.5 %, respectively) [25].
The unstable aneurysm group included ruptured aneu-
rysms, aneurysms with change in morphology, and
symptomatic aneurysms [25]. Identification of aneurysm
wall enhancement could correspond to vasa vasorum
formation and inflammatory activity, and it may relate
to the aneurysm’s risk of rupture [14, 24, 25]. A pro-
spective study could confirm the role of VWI in the
non-invasive follow-up of unruptured aneurysms [25].
Moyamoya disease
Moyamoya disease (MMD) is an idiopathic disorder
causing progressive narrowing of the distal intracranial
internal carotid arteries (ICAs) and the proximal circle
of Willis vessels, and is characterized by the develop-
ment of hypertrophied lenticulostriate branches. MMD
and ICAD are both more prevalent in Asians, and differ-
entiation between the two conditions is important be-
cause of different treatment strategies (revascularization
surgery in MMD versus aggressive medical treatment in
ICAD) [26]. Prior reports have suggested that MMD is
characterized by little to no wall enhancement, and that
this could differentiate it from radiation-induced arter-
itis, which presents with concentric enhancement, or an
ICAD lesion that presents with eccentric enhancement
[3, 27, 28]. More recent studies have described
concentric enhancement in symptomatic and asymptom-
atic MMD patients affecting the distal ICAs, which
could correspond to intimal hyperplasia pathologically
[1, 26, 29]. Ryoo et al. suggested that concentric wall en-
hancement in bilateral distal ICAs and shrinkage of the
middle cerebral arteries in MMD can distinguish it from
ICAD, which presents with focal eccentric enhancement
on BBMRI [26]. Additional studies are needed to further
investigate the appearance of MMD using optimized
BBMRI imaging and clarify whether a noninvasive diag-
nosis can be made.
Dissection
Dissection represents blood tracking into the vessel
wall through an intimal tear. BBMRI findings suggest-
ive of dissection include eccentric wall thickening
with T1 hyperintense signal representing intramural
hematoma, the identification of a false lumen, and ec-
centric wall enhancement, which might imply involve-
ment by vasa vasorum [3, 14, 30]. However, the
hyperintense T1 vessel wall signal is not specific for
dissection since it could represent intraplaque
hemorrhage in an ICAD lesion [3, 5], and studies
have yet to validate these imaging features given the
general lack of intracranial vessel specimens for com-
parison [3].
Conclusions
VWI is a rapidly growing and evolving area of clinical
and research interest that holds promise to improve
diagnostic accuracy for intracranial vasculopathies. VWI
enables direct visualization of offending vessel wall path-
ology, which wouldn’t be detectable on conventional im-
aging unless it resulted in luminal narrowing. Specific
vessel wall thickening and enhancement patterns have
been described in several conditions with similar angio-
graphic findings enabling discrimination of these dis-
eases that was not previously possible. VWI appears to
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allow for assessment of atherosclerotic burden and for
risk stratification of individual ICAD lesions with poten-
tial to influence treatment decisions. Further prospective
studies are needed to better define the role of VWI in
predicting risk from intracranial vasculopathies and de-
termining the best management approach.
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